Therapeutic Drug Monitoring of Sunitinib and Pazopanib in Advanced or Metastatic Renal Cell Carcinoma

NCT02555748 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Renal Cell Cancer

Interventions

DRUG: Pazopanib
DRUG: Sunitinib

Sponsor

Institut Claudius Regaud

Collaborators

[object Object]